ursodeoxycholic acid has been researched along with Cytokine Release Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abdulrab, S; Al-Maweri, S; Halboub, E | 1 |
1 other study(ies) available for ursodeoxycholic acid and Cytokine Release Syndrome
Article | Year |
---|---|
Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm.
Topics: Anti-Inflammatory Agents; Apoptosis; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2; Ursodeoxycholic Acid | 2020 |